Down-modulation of CD8αβ is a fundamental activity of primate: Lentiviral nef proteins

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 36-48

  Heigele, Anke ^a   Schindler, Michael ^a,c   Gnanadurai, Clement W ^a   Leonard, Jolie A ^b   Collins, Kathleen L ^b   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8ALPHA BETA ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; LYMPHOCYTE ANTIGEN; NEF PROTEIN; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ANTIGENIC MODULATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; LONG TERMINAL REPEAT; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; RECEPTOR DOWN REGULATION; SIMIAN IMMUNODEFICIENCY VIRUS; SITE DIRECTED MUTAGENESIS; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; GENE PRODUCTS, NEF; HUMANS; LENTIVIRUS INFECTIONS; LENTIVIRUSES, PRIMATE;

HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84855918309     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00717-11     Document Type: Article

References (74)

1. Aiken C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:5871-5877.
2. Akari H, et al. 2000. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74:2907-2912.
3. Arhel N, et al. 2009. The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J. Clin. Invest. 119:2965-2975.
4. Ariën KK, Verhasselt B. 2008. HIV Nef: role in pathogenesis and viral fitness. Curr. HIV Res. 6:200-208.
5. Atkins KM, et al. 2008. HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice. J. Biol. Chem. 283:11772-11784.
6. Bailes E, et al. 2003. Hybrid origin of SIV in chimpanzees. Science 300: 1713.
7. Bresnahan PA, Yonemoto W, Greene WC. 1999. Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4. J. Immunol. 163:2977-2981.
8. Carlson JM, Brumme ZL. 2008. HIV evolution in response to HLArestricted CTL selection pressures: a population-based perspective. Microbes Infect. 10:455-461.
9. Chopera DR, et al. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4:e1000033.
10. Cochrane A, et al. 2004. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo. J. Virol. 78: 9862-9871.
11. Cohen GB, et al. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661-671.
12. Coleman SH, et al. 2006. Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif. J. Virol. 80:1837-1849.
13. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. 1998. HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-400.
14. Craig HM, Pandori MW, Guatelli JC. 1998. Interaction of HIV 1 Nef with the cellular dileucine based sorting pathway is required for CD4 down regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. U. S. A. 95:11229-11234.
15. DeGottardi MQ, et al. 2008. Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by Nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2. J. Virol. 82:3139-3146.
16. Delarbre C, Nakauchi H, Bontrop R, Kourilsky P, Gachelin G. 1993. Duplication of the CD8 beta-chain gene as a marker of the man-gorillachimpanzee clade. Proc. Natl. Acad. Sci. U. S. A. 90:7049-7053.
17. De Rossi A, et al. 1990. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res. Hum. Retroviruses 6:287-298.
18. Flamand L, et al. 1998. Activation of CD8+T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 95:3111-3116.
19. Gangadharan D, Cheroutre H. 2004. The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR coreceptor CD8alphabeta. Curr. Opin. Immunol. 16:264-270.
20. Geyer M, Fackler OT, Peterlin BM. 2001. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2:580-585.
21. Goldrath AW, Hogquist KA, Bevan MJ. 1997. CD8 lineage commitment in the absence of CD8. Immunity 6:633-642.
22. Greenberg ME, Iafrate AJ, Skowronski J. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17:2777-2789.
23. Hahn BH, Shaw GM, De Cock KM, Sharp PM. 2000. AIDS as a zoonosis: scientific and public health implications. Science 287:607-614.
24. Hanson A, et al. 2005. Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection. AIDS Res. Hum. Retroviruses 21:791-798.
25. Hua J, Cullen BR. 1997. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4. J. Virol. 71:6742-6748.
26. Iafrate AJ, Bronson S, Skowronski J. 1997. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16:673-684.
27. Janvier K, et al. 2001. Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. J. Virol. 75: 3971-3976.
28. Jia B, et al. 2009. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5:e1000429.
29. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67.
30. Kirchhoff F, Schindler M, Specht A, Arhel N, Münch J. 2008. Role of Nef in primate lentiviral immunopathogenesis. Cell. Mol. Life Sci. 65: 2621-2636.
31. Kitchen SG, Korin YD, Roth MD, Landay A, Zack JA. 1998. Costimulation of naive CD8+ lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J. Virol. 72:9054-9060.
32. Le Gall S, et al. 2000. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I downregulation. J. Virol. 74:9256-9266.
33. Le Gall S, et al. 1998. Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC 1 molecules. Immunity 8:483-495.
34. Leitner T, et al. 2003. HIV sequence compendium. LA-UR 04-7420. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
35. Leonard JA, Filzen T, Carter CC, Schaefer M, Collins KL. 2011. HIV-1 Nef disrupts intracellular trafficking of MHC-I, CD4, CD8, and CD28 by distinct pathways that share common elements. J. Virol. 85:6867-6881.
36. Lindwasser OW, et al. 2008. A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J. Virol. 82:1166-1174.
37. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM. 1998. Interactions between HIV-1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8:647-656.
38. Marlink RG, et al. 1988. Clinical, hematological, and immunologic crosssectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res. Hum. Retroviruses 4:137-148.
39. Miura T, et al. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition. J. Virol. 83:2743-2755.
40. Münch J, et al. 2007. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J. Virol. 81:13852-13864.
41. Münch J, et al. 2005. Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication. J. Virol. 79:10547-10560.
42. Münch J, Stolte N, Fuchs D, Stahl-Hennig C, Kirchhoff F. 2001. Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. J. Virol. 75:10532-10536.
43. Pepin J, et al. 1991. HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 5:1165-1172.
44. Piguet V, et al. 1999. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97:63-73.
45. Piguet V, et al. 2000. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2:163-167.
46. Pulkkinen K, Renkema GH, Kirchhoff F, Saksela K. 2004. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J. Virol. 78:12773-12780.
47. Quaranta MG, Mattioli B, Giordani L, Viora M. 2004. HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion. FASEB J. 18:1459-1461.
48. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K. 1999. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9:1407-1410.
49. Saha K, et al. 2001. Isolation of primary HIV-1 that targets CD8+ T lymphocytes using CD8 as a receptor. Nat. Med. 7:65-72.
50. Saha K, Zhang J, Zerhouni B. 2001. Evidence of productively infected CD8+T cells in patients with AIDS: implications for HIV-1 pathogenesis. J. Acquir. Immune Defic. Syndr. 26:199-207.
51. Saksela K, Cheng G, Baltimore D. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
52. Sauter D, et al. 2009. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6:409-421.
53. Schaefer MR, Wonderlich ER, Roeth JF, Leonard JA, Collins KL. 2008. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog. 4:e1000131.
54. Schindler M, et al. 2004. Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques. J. Virol. 78: 10588-10597.
55. Schindler M, et al. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055-1067.
56. Schindler M, et al. 2003. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77:10548-10556.
57. Schmitz JE, et al. 1998. Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals. Blood 92:198-206.
58. Schmökel J, et al. 2011. The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses. J. Virol. 85:742-752.
59. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
60. Sharp PM, Hahn BH. 2010. The evolution of HIV-1 and the origin of AIDS. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365:2487-2494.
61. Sodora DL, et al. 2009. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat. Med. 15:861-865.
62. Specht A, et al. 2008. Selective down-modulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses. Virology 373: 229-237.
63. Stove V, et al. 2005. Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8αβ. J. Virol. 79:11422-11433.
64. Stumptner-Cuvelette P, et al. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U. S. A. 98:12144-12149.
65. Swigut T, Iafrate AJ, Münch J, Kirchhoff F, Skowronski J. 2000. SIV and HIV Nef proteins use different surfaces to downregulate class I major histocompatibility antigen expression. J. Virol. 74:5691-5701.
66. Swigut T, et al. 2004. Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J. Virol. 78:13335-13344.
67. Thakral D, Dobbins J, Devine L, Kavathas PB. 2008. Differential expression of the human CD8beta splice variants and regulation of the M-2 isoform by ubiquitination. J. Immunol. 180:7431-7442.
68. Veazey RS, et al. 2000. Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J. Virol. 74:11001-11007.
69. Wang X, Das A, Lackner AA, Veazey RS, Pahar B. 2008. Intestinal double-positive CD4+CD8+ T cells of neonatal rhesus macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection. Blood 112:4981-4990.
70. Wonderlich ER, Leonard JA, Collins KL. 2011. HIV immune evasion disruption of antigen presentation by the HIV Nef protein. Adv. Virus Res. 80:103-127.
71. Xu XN, et al. 1997. Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186:7-16.
72. Zerhouni B, Nelson JA, Saha K. 2004. Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes. J. Virol. 78: 1243-1255.
73. Zhang F, et al. 2011. SIV Nef proteins recruit the AP-2 complex to antagonize tetherin and facilitate virion release. PLoS Pathog. 7:e1002039.
74. Zhang F, et al. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6:54-67.